Trials in Long Beach, California
Here are the top 10 medical studies for prostate cancer in Long Beach, California
Popular Filters
Phase 3 Trials
Taxane
Capivasertib + Docetaxel for Prostate Cancer
Recruiting1 awardPhase 3
Cerritos, California
This trial will compare the effect of two different treatments for metastatic prostate cancer. One group will receive a combination of capivasertib and docetaxel, while the other group will receive docetaxel and a placebo. The goal is to see if adding capivasertib to docetaxel improves survival rates.
Radiation
Shorter vs Usual Radiation Therapy for Prostate Cancer
Recruiting2 awardsPhase 3
Orange, California
This trial is comparing two different types of radiation therapy for high-risk prostate cancer. One type, called stereotactic body radiation therapy (SBRT), involves giving higher doses of radiation over a shorter period
Hormone Therapy
Opevesostat + Hormone Therapy for Prostate Cancer
Recruiting2 awardsPhase 3
Orange, California
This trial is testing a new drug called opevesostat for advanced prostate cancer patients who don't respond to usual care. The drug aims to stop the cancer from growing and spreading, potentially helping patients live longer.
Hormone Therapy
AZD5305 for Prostate Cancer
Recruiting1 awardPhase 3
Fountain Valley, California
This trial is testing a new drug called Saruparib combined with hormone treatment in adults with prostate cancer that has spread but still responds to hormones. The drug aims to stop cancer cells from repairing themselves, potentially slowing down the disease.
Trials With No Placebo
Hormone Therapy
Neoadjuvant PARP Inhibition + Hormone Therapy for Prostate Cancer
Recruiting1 awardPhase 2
La Jolla, California
This trial tests a drug+hormone combo to treat prostate cancer in men with genetic mutations. After 6 mo. of treatment, patients will have surgery to remove cancer and be followed for recovery & progression.
Radioactive Drug
Lutetium PSMA + SBRT for Prostate Cancer
Recruiting1 awardPhase 2
Los Angeles, California
This trial tests if using a radioactive drug, 177-Lutetium-PSMA, before precise radiation therapy can better control prostate cancer that has returned in patients with 1-5 tumors. The drug targets cancer cells directly, and the radiation therapy aims to kill these cells with high precision and fewer side effects. Lutetium-177 (Lu-177) labeled PSMA has shown promising outcomes in treating advanced prostate cancer, including reduced disease progression and improved overall survival.
Antibody-Drug Conjugate
Dato-DXd Combination Therapy for Advanced Cancers
Recruiting1 awardPhase 2
Los Angeles, California
This trial is testing Dato-DXd, a targeted cancer treatment, in patients with advanced or metastatic solid tumors. The treatment aims to deliver chemotherapy directly to cancer cells, helping to kill them while reducing harm to healthy cells.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.